Butterfly Thyroid Cancer Trust is the first national supporter of patients with Thyroid Cancer.
As a group dedicated solely to the support of patients with Thyroid Cancer we can offer fellow thyroid cancer patients who wish to join us the following:
Welcome to Butterfly Thyroid Cancer Trust
- Use of the dedicated helpline to speak to someone who has had the disease.
- E-mail and telephone contact with group members to share experiences
- A "buddy" to help you through the stages of surgery, Radioiodine treatment and follow up
- Access to reliable up-to-date written information about the disease
- Access to a group member in clinic at the Northern Centre for Cancer Care (NCCC), Freeman Hospital
We are available on this number on Tuesdays and Fridays from 10 am to 4 pm. Outside these times, please leave a message on our answer phone and we will get back to you as soon as we can.
Your Treatment Journey
Thyroid Cancer has an 80-90% cure rate. Find out about the steps you might take in your journey towards recovery.
About Thyroid Cancer
Learn about the different types of Thyroid Cancer, and which types of treatments are available to patients.
I131 Treatment
Useful information regarding Radioiodine (I131) treatment.
Thyroid Cancer Forum 2016
Butterfly hosted the first ever UK Patient/Doctor Thyroid Cancer Forum on 5th December 2016 in London.
Click one of the links below to watch a video of the event.
Thyroid Cancer Patient Information DVD
Do you have progressed or advanced thyroid cancer? Watch the trailer for ‘ Christine’s Story - living with advanced thyroid cancer
Watch our film “ The Butterfly Effect” to learn how Butterfly began
Latest News
A new clinical trial is being proposed for people whose thyroid cancer is deemed ‘low risk and we would like to know how patients feel about this . If you were told that your thyroid cancer when you were given the diagnosis please could you help us by taking this short survey? Many thanks ! […]
Read More >>
NICE have finally given their decision on Lenvatenib and Sorafenib. Both drugs are recommended for the treatment of thyroid cancer which is no longer taking up RAI. However,patients can only have access to one of the drugs. This means that patients who are already taking Sorafenib will not be able to have Lenvatenib when and […]
Read More >>
Butterfly hosted the first ever UK Patient/Doctor Thyroid Cancer Forum on 5th December 2016 in London.
Read More >>
Excellence in Oncology
'Bright Ideas'
Highly Recommended
